Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatment

This study aimed to molecularly characterise colorectal pulmonary metastases (PM) and investigate whether their molecular profiles were concordant with those of the primary tumour. Clinical data and archival formalin fixed paraffin embedded tissue samples were retrospectively collected from patients...

Full description

Saved in:

Bibliographic Details
Published in:	Oncotarget 2017-09, Vol.8 (39), p.64999-65008
Main Authors:	Moorcraft, Sing Y, Jones, Thomas, Walker, Brian A, Ladas, George, Kalaitzaki, Eleftheria, Yuan, Lina, Begum, Ruwaida, Eltahir, Zakaria, Wotherspoon, Andrew, Montero-Fernandez, Angeles, Teixeira Mendes, Larissa S, Gonzalez de Castro, David, Wilson, Sanna Hulkki, Proszek, Paula, To, Ye M, Hawkes, Eliza, Roy, Amitesh, Cunningham, David, Rao, Sheela, Watkins, David, Starling, Naureen, Bowcock, Anne M, Chau, Ian
Format:	Article
Language:	eng
Subjects:	Research Paper
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	This study aimed to molecularly characterise colorectal pulmonary metastases (PM) and investigate whether their molecular profiles were concordant with those of the primary tumour. Clinical data and archival formalin fixed paraffin embedded tissue samples were retrospectively collected from patients who underwent ≥ 1 pulmonary metastasectomies for colorectal cancer between 1997-2012. Primary tumour and metastatic samples were analysed using a targeted capture sequencing panel of 46 cancer-associated genes. The 5-year progression-free and overall survival rates for the 81 patients in this study were 32% (95% CI 22-42%) and 77% (95% CI 66-85%) respectively. Fifty-four patients had samples available from ≥ 1 PM, and sequencing data were successfully obtained from 33 PM from 24 patients. The most frequently mutated genes were (71%), (58%) and (46%). Seventy-three percent of the 15 patients with matched primary and PM samples and 6 of the 7 patients (86%) with data from ≥ 2 PM had concordant molecular profiles. The concordance for and was 100%. At our institutions, patients with resectable colorectal PM had a favourable prognosis. RAS mutations were commonly detected in PM and the molecular profiles of colorectal PM were highly concordant with the primary tumour.
ISSN:	1949-2553 1949-2553